Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 2 , Pages 129-134 , February 2010

Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro™ Cd polymerase chain reaction as confirmatory procedures

  • Kirk M. Doing

      Affiliations

    • Affiliated Laboratory, Inc., Bangor, ME 04401, USA
    • Department of Biology and Ecology, University of Maine, Orono, ME 04469, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-207-973-6900; fax: +1-207-973-6999.
    • ,
  • Marilyn S. Hintz

      Affiliations

    • Affiliated Laboratory, Inc., Bangor, ME 04401, USA
    • ,
  • Calvin Keefe

      Affiliations

    • Affiliated Laboratory, Inc., Bangor, ME 04401, USA
    • ,
  • Sarah Horne

      Affiliations

    • Department of Biology and Ecology, University of Maine, Orono, ME 04469, USA
    • ,
  • Shelby LeVasseur

      Affiliations

    • Department of Biology and Ecology, University of Maine, Orono, ME 04469, USA
    • ,
  • Martha L. Kulikowski

      Affiliations

    • Affiliated Laboratory, Inc., Bangor, ME 04401, USA

Received 17 July 2009 ,Accepted 2 September 2009.

References 

  1. Aichinger E, Schleck CD, Harmsen WS, Nyrem LM, Patel R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or immunoassay. J. Clin. Microbiol. 2008;46:3795–3797
  2. Alcalá L, Sánchez-Cambronero L, Catalán MP, Sánchez-Somolinos M, Peláez MT, Marín M, et al. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J. Clin. Microbiol. 2008;46:3833–3835
  3. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann. Intern. Med. 2006;145:758–764
  4. Benson L, Song X, Campos J, Singh N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect. Control Hosp. Epidemiol. 2007;28:1233–1235
  5. Cardona DM, Rand KH. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J. Clin. Microbiol. 2008;46:3686–3689
  6. Curry SR, Marsh JW, Muto CA, O'Leary MM, Pasculle AW, Harrison LH. tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J. Clin. Microbiol. 2007;45:215–221
  7. Delmée M, Van Broeck J, Simon A, Janssens M, Avesani V. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J. Med. Microbiol. 2005;54:187–191
  8. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am. J. Gastroenterol. 1997;92:739–750
  9. Fenner L, Widmer AF, Goy G, Rudin S, Frei R. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J. Clin. Microbiol. 2008;46:328–330
  10. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J. Society for healthcare epidemiology of America position paper on Clostridium difficile-associated diarrhea and colitis. Infect. Control Hosp. Epidemiol. 1995;16:459–477
  11. Gilligan PH. Is a two-step glutamate dehydrogenase antigen-cytotoxicity neutralization assay algorithm superior to the Premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile. J. Clin. Microbiol. 2008;46:1523–1525
  12. Kelly CP, LaMont JT. Clostridium difficile—more difficult than ever. N. Engl. J. Med. 2008;359:1932–1940
  13. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect. 2006;12:2–18
  14. McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 2005;353:2433–2505
  15. Mehlig M, Moos M, Braun V, Kalt B, Mahoney DE, von Eichel-Streiber C. Variant toxin B and a functional toxin A produced by Clostridium difficile C34. FEMS. Microbiol. Lett. 2001;198:171–176
  16. Miller AD, Smith KM, Winstead PS, Martin CA. Clostridium difficile-associated diarrhea: a review and update on changes in disease virulence and treatment response. Pharmacol. Ther. 2006;31:510–520
  17. Mundy LS, Shanholtzer CJ, Willard KE, Gerding DN, Peterson LR. Laboratory detection of Clostridium difficile. A comparison of media, and incubation systems. Am. J. Clin. Pathol. 1995;103:52–56
  18. Musher DM, Manhas A, Jain P, Nuila F, Waqar A, Logan N, et al. Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. J. Clin. Microbiol. 2007;45:2737–2739
  19. Peterson LR, Manson U, Paule SM, Hacek DM, Robicsek A, Thomson RB, et al. Detection of toxigenic Clostridium difficile in stool sample by real-time polymerase chain reaction for the diagnosis of C. difficile-associated disease. Clin. Infect. Dis. 2007;45:1152–1160
  20. Reller ME, Lema CA, Perl TM, Cai M, Ross TL, Speck KA, et al. Yield of stool culture isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 2007;45:3601–3605
  21. Sloan LM, Duresko BJ, Gustafson DR, Rosenblatt JE. Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J. Clin. Microbiol. 2008;46:1996–2001
  22. Snell H, Ramos S, Longo S, John M, Hussain Z. Performance of the TechLab C. DIF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 2004;42:4863–4865
  23. Söderblom TA, Blaxhult A, Fredland H, Herman B. Impact of a genetic variant of Chlamydia trachomatis on national detection rates in Sweden. Eurosurveillance. 2006;11:
  24. Stamper PD, Alcabasa R, Aird D, Babiker W, Wehrlin J, Ikpeama I, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J. Clin. Microbiol. 2009;47:373–378
  25. Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J. Clin. Microbiol. 2006;44:1145–1149
  26. Turgeon DK, Novicki TJ, Quick J, Carlson L, Miller P, Ulness B, et al. Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J. Clin. Microbiol. 2003;41:667–670
  27. van den Berg RJ, Vaessen N, Endtz HP, Schülin T, van der Vorm ER, Kuijper EJ. Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective mutlicentre study. J. Med. Microbiol. 2007;56:36–42
  28. Voth DE, Ballard JD. Clostridium difficile toxins: mechanisms of action and role in disease. Clin. Microbiol. Rev. 2005;18:247–263
  29. Whittier S, Shapiro DS, Kelly WF, Walden TP, Wait KJ, McMillon LT, et al. Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated disease. J. Clin. Microbiol. 1993;31:2861–2865
  30. Zheng L, Keller SE, Lyerly DM, Carman RJ, Genheimer CW, Gleaves CA, et al. Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J. Clin. Microbiol. 2004;42:3837–3840

☆ Work performed at Affiliated Laboratory.

PII: S0732-8893(09)00364-2

doi: 10.1016/j.diagmicrobio.2009.09.001

Diagnostic Microbiology & Infectious Disease
Volume 66, Issue 2 , Pages 129-134 , February 2010

Article Tools